Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Benitec Biopharma (BNTC) Change in Accured Expenses (2019 - 2025)

Benitec Biopharma (BNTC) has disclosed Change in Accured Expenses for 7 consecutive years, with -$163000.0 as the latest value for Q2 2025.

  • Quarterly Change in Accured Expenses fell 1711.11% to -$163000.0 in Q2 2025 from the year-ago period, while the trailing twelve-month figure was -$81000.0 through Jun 2025, down 307.69% year-over-year, with the annual reading at -$81000.0 for FY2025, 307.69% down from the prior year.
  • Change in Accured Expenses hit -$163000.0 in Q2 2025 for Benitec Biopharma, down from $159000.0 in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $159000.0 in Q1 2025 to a low of -$163000.0 in Q2 2025.
  • Historically, Change in Accured Expenses has averaged $11500.0 across 5 years, with a median of $11000.0 in 2022.
  • Biggest YoY gain for Change in Accured Expenses was 7850.0% in 2025; the steepest drop was 1711.11% in 2025.
  • Year by year, Change in Accured Expenses stood at $3000.0 in 2021, then surged by 100.0% to $6000.0 in 2022, then skyrocketed by 733.33% to $50000.0 in 2023, then tumbled by 286.0% to -$93000.0 in 2024, then tumbled by 75.27% to -$163000.0 in 2025.
  • Business Quant data shows Change in Accured Expenses for BNTC at -$163000.0 in Q2 2025, $159000.0 in Q1 2025, and -$93000.0 in Q4 2024.